Delisting riskPopularity #4,237
Akari Therapeutics (ADR) (AKTX)
Develops preclinical oncology antibody-drug conjugates based on its PH1 payload platform.
$9.45
vs last close−0.60 (−5.97%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 13.10% | 150.0K ADS | |
|---|---|---|---|
| 10 holders · as of Jun 30, 2026 | |||
| Insiders | 2.13% | 24.4K ADS | |
| 2 holders · as of Aug 19, 2026 | |||
| Other | 84.77% | 970.2K ADS | |
| remainder | |||
1.14M ADS as of Aug 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
Some positions are filed in underlying shares, not receipts; the ratio is unknown, so no percentage.
A stock split fell inside the quarter, so quarter-on-quarter changes are not shown.
13F, as of Jun 30, 2026
10 holders · 150.0K shares
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Mmcap International Inc. SPC | 100.0K | 8.74% | Aug 14, 2026 | |
| Cresset Asset Management, LLC | 20.6K | 1.80% | Aug 14, 2026 | |
| Jane Street Group, LLC | 15.5K | 1.35% | Aug 14, 2026 | |
| HRT Financial LP | 13.7K | 1.20% | Aug 14, 2026 | |
| Ifp Advisors, Inc | 181 | 0.02% | Jul 20, 2026 | |
| Sbi Securities Co., Ltd. | 14 | 0.00% | Jul 23, 2026 | |
| Caitong International Asset Management Co., Ltd | 8 | 0.00% | Aug 5, 2026 | |
| Northwestern Mutual Wealth Management Co | 7 | 0.00% | Aug 12, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Hoyoung Huh, M.D., Ph.D. | 18.40% | 13G | Mar 4, 2026 | |
| Samir R. Patel | 10.40% | 13D | Mar 4, 2026 | |
| Ray Prudo, M.D.incl. Praxis Trustees Limited as trustee of the Sonic Healthcare Holding Company, RPC Pharma Limited | 8.90% | 13D | Mar 4, 2026 | |
| MMCAP International Inc. SPC | 8.00% | 13G | Jun 8, 2026 | |
| Bank of Montreal | 5.71% | 13G | Aug 12, 2026 | |
| White Lion Capital LLC | 5.00% | 13G | Aug 7, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Dec 16, 2025 | James R. Nealdirector | Purchase · 4 lots | 11,132 | $0.3883 | 8,659 |
| Dec 16, 2025 | Robert B. Bazemoredirector | Purchase · 4 lots | 309,326 | $0.3883 | 278,394 |
| Dec 16, 2025 | Abizer Gaslightwaladirector, officer: CEO | Purchase · 4 lots | 2,165,302 | $0.3883 | 1,855,974 |
| Dec 16, 2025 | Samir Rashmikant Pateldirector, 10 percent owner: | Purchase · 4 lots | 1,701,310 | $0.3883 | 1,701,310 |
| Dec 16, 2025 | Kameel D. Faragofficer: Interim CFO | Purchase · 2 lots | 49,490 | $0.3883 | 49,490 |
| Dec 16, 2025 | Hoyoung Huhdirector, 10 percent owner: | Purchase · 4 lots | 7,423,902 | $0.3883 | 6,805,244 |
| Dec 16, 2025 | Sandip I. Pateldirector | Purchase · 4 lots | 804,252 | $0.3883 | 649,588 |
| Dec 16, 2025 | Raymond Prudo-Chleboszdirector | Purchase · 4 lots | 2,010,638 | $0.3883 | 1,623,977 |
House and Senate disclosures
Not reported.
